Skip to main content
Year archive

Formycon AG — 2014 filings

All 12 regulatory filings released by Formycon AG (FYB) in 2014, sourced directly from the official regulator.

12 Filings
2014 Period
2014 filings (12)
Filing Released Lang
Formycon AG moves planned start of pivotal phase III study for its first biosimilar product (FYB201) forward to 3Q 2015
Regulatory Filings
2014-11-18 English
Formycon AG release nine-month figures for 2014
Earnings Release 9M 2014
2014-10-16 English
Formycon AG berichtet Ergebnisse fur das erste Halbjahr 2014 (KORREKTUR)
Earnings Release H1 2014
2014-09-23 German
Formycon AG announces its results for the first half of 2014
Earnings Release H1 2014
2014-09-23 English
Halbjahresabschluss 2014
Interim / Quarterly Report H2 2014
2014-09-23 German
Datum:20.08.2014
Annual Report FY 2013
2014-08-20 German
Jahresabschluss 2013
Audit Report / Information FY 2013
2014-06-25 German
Formycon AG startet mit der Entwicklung des dritten Produktes und bestatigt Vorreiterrolle bei der sogenannten Dritten Welle der Biosimilars
Regulatory Filings
2014-06-16 German
Formycon AG announces financial results of fiscal year 2013 and first quarter results of fiscal year 2014
Earnings Release Q1 2014
2014-05-12 English
Formycon AG: Strong partner increases marketing potential for the first biosimilar development project
M&A Activity
2014-03-25 English
Formycon AG appoints top US pharmaceuticals manager Bernhard Hampl to the Advisory Board
Board/Management Information
2014-03-13 English
Datum:03.01.2014
Annual Report FY 2012
2014-01-03 German